Enterprise AI Agents Need Orchestration, Not Just Deployment

When a new drug clears FDA approval, health insurers face a coverage decision that typically requires six or seven specialists working sequentially over two to three months at a cost near $100,000. For medications treating conditions like schizophrenia, delays trigger hospitalizations costing plans $8,000 to $15,000 each — potentially adding millions in avoidable expenses across a single large plan.

This workflow problem illustrates a broader challenge facing enterprise AI deployments: organizations are racing to deploy autonomous agents without building the systems needed to coordinate, govern, and audit them.

Why it matters

MIT researchers analyzing more than 300 enterprise AI deployments found that 95% of generative AI pilots produced no measurable return — not because models were inadequate, but because companies grafted AI onto processes never redesigned for it. Gartner predicts over 40% of agentic AI projects will be canceled by end of 2027, citing inadequate risk controls alongside cost and unclear value. Healthcare's regulatory environment and expertise shortages are forcing the industry to confront orchestration challenges other sectors will soon face.

The automation trap

Most enterprise AI implementations follow a familiar pattern: automate individual steps within existing workflows, declare victory, and move on. The approach mirrors what happened with cloud migration a decade ago, when companies lifted legacy processes onto new infrastructure without rethinking how work should be done.

Healthcare makes this dysfunction visible quickly. The American Medical Association's 2024 physician survey found prior authorization alone consumes an average of 13 hours of physician and staff time weekly, with 93% of physicians reporting it delays patient care. One health enterprise employs 600 nurses whose primary role is prior authorization and payment integrity — clinically trained professionals spending their days on paperwork.

The Association of American Medical Colleges projects a shortage of up to 86,000 physicians by 2036, while nursing shortages intensify. Technology was supposed to alleviate administrative burden. Instead, it mostly digitized filing cabinets.

Coordinated agents versus point solutions

For pharmacy benefit managers and health plans, a new drug approval assessment involving pharmacists, coders, actuaries, and compliance counsel typically spans 60 to 90 days at roughly $100,000 per drug. Large PBMs run 200 to 300 such assessments annually while patients wait in coverage limbo.

The same assessment using coordinated AI agents takes four to eight hours, with clinical pharmacists reviewing output rather than producing it from scratch. Direct labor costs drop 97%, and crucially, every agent action is documented for compliance traceability.

The distinction matters. Deploying a thousand ungoverned agents recreates the problem enterprises faced with disconnected point solutions — except now the systems make autonomous decisions requiring audit trails.

What regulated industries can learn

Healthcare didn't volunteer to confront AI orchestration first. Administrative burden is driving clinicians from the profession, coverage processes are failing, and regulatory requirements demand decision traceability. That pressure is forcing the industry to address not just how to deploy AI, but how to govern and audit it.

Financial services, insurance, energy, and government face identical challenges: expertise trapped in workflows, increasing regulations, and decisions requiring transparency. The question isn't whether AI can perform tasks — it's whether organizations can understand, govern, and trust the decisions AI helps produce.

The current AI conversation centers on agent autonomy and deployment velocity. Almost nobody is building orchestration systems to manage them. That's the infrastructure gap that will determine which AI investments deliver returns and which join the 95% producing no measurable value.

These details were first reported by Autonomize AI founder Prashant Kelker, writing in Fortune based on his experience at Dell and in healthcare technology startups.